Skip to Main Content

Paper Details

Genome-Wide Meta-Analysis Identifies Variants in <i>DSCAM</i> and <i>PDLIM3</i> That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib.
Cancers (Basel)
2
2022
Metastatic Renal Cell Carcinoma, Patients, SNPs, Sunitinib, genes, genetic variants, mRCC, metastatic renal cell carcinoma, patients, rs111356738, rs2205096, rs28520013, single nucleotide polymorphisms, sunitinib
Author NameAffiliation
Jes??s Garc??a-DonasHM Hospitales-Centro Integral Oncologico HM Clara Campal
Cristina Rodr??guez-AntonaSpanish National Cancer Research Center (CNIO) and Biomedical Network on Rare Diseases (CIBERER)
Stefan BöhringerLeiden University Medical Center
Stefan BöhringerLeiden University Medical Center
Michiaki KuboRIKEN Center for Integrative Medical Sciences
Lambertus A KiemeneyRadboud University Medical Center
  • 1 - 6

Datasets

Release 1.2